Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex
被引:44
|
作者:
Panter, Michaela S.
论文数: 0引用数: 0
h-index: 0
机构:
Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USAYale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
Panter, Michaela S.
[1
,2
]
Jain, Ankur
论文数: 0引用数: 0
h-index: 0
机构:
Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA
Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USAYale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
Jain, Ankur
[3
,4
]
Leonhardt, Ralf M.
论文数: 0引用数: 0
h-index: 0
机构:
Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USAYale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
Leonhardt, Ralf M.
[1
]
Ha, Taekjip
论文数: 0引用数: 0
h-index: 0
机构:
Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA
Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA
Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USAYale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
Ha, Taekjip
[3
,4
,5
]
Cresswell, Peter
论文数: 0引用数: 0
h-index: 0
机构:
Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USAYale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
Cresswell, Peter
[1
,2
]
机构:
[1] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA
[3] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA
[4] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA
[5] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA
Although the human peptide-loading complex (PLC) is required for optimal major histocompatibility complex class I (MHC I) antigen presentation, its composition is still incompletely understood. The ratio of the transporter associated with antigen processing (TAP) and MHC I to tapasin, which is responsible for MHCI recruitment and peptide binding optimization, is particularly critical for modeling of the PLC. Here, we characterized the stoichiometry of the human PLC using both biophysical and biochemical approaches. By means of single-molecule pulldown (SiMPull), we determined a TAP/tapasin ratio of 1: 2, consistent with previous studies of insect-cell microsomes, rat-human chimeric cells, and HeLa cells expressing truncated TAP subunits. We also report that the tapasin/MHC I ratio varies, with the PLC population comprising both 2: 1 and 2: 2 complexes, based on mutational and co-precipitation studies. The MHC I-saturated PLC may be particularly prevalent among peptide-selective alleles, such as HLA-C4. Additionally, MHC I association with the PLC increases when its peptide supply is reduced by inhibiting the proteasome or by blocking TAP-mediated peptide transport using viral inhibitors. Taken together, our results indicate that the composition of the human PLC varies under normal conditions and dynamically adapts to alterations in peptide supply that may arise during viral infection. These findings improve our understanding of the quality control of MHC I peptide loading and may aid the structural and functional modeling of the human PLC.